Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine

NCT00323375 is registered in ClinicalTrials.gov with Tulane University Health Sciences Center as lead sponsor.

NCT NCT00323375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00323375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial of AQ-13, a Candidate Aminoquinoline Antimalarial, in Comparison With Chloroquine
Lead sponsor
Tulane University Health Sciences Center
Phase
Phase 1
Overall status
Completed
Start date
August 1, 1999
Completion date
August 31, 2005
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria